# Manipulating Ghrelin Signaling Via GOAT Inhibition in Alcohol Use Disorder

> **NCT03896516** · PHASE1,PHASE2 · COMPLETED · sponsor: **National Institute on Drug Abuse (NIDA)** · enrollment: 21 (actual)

## Conditions studied

- Alcohol Use Disorder

## Interventions

- **OTHER:** Placebo
- **DRUG:** GLWL-01

## Key facts

- **NCT ID:** NCT03896516
- **Lead sponsor:** National Institute on Drug Abuse (NIDA)
- **Sponsor class:** NIH
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-22
- **Primary completion:** 2023-12-04
- **Final completion:** 2023-12-04
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2025-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03896516

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03896516, "Manipulating Ghrelin Signaling Via GOAT Inhibition in Alcohol Use Disorder". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03896516. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*